These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33652588)

  • 21. Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing.
    Burns C; Bagnall RD; Lam L; Semsarian C; Ingles J
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28790153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated reanalysis application to assist in detecting novel gene-disease associations after genome sequencing.
    Mensah NE; Sabir AH; Bond A; Roworth W; Irving M; Davies AC; Ahn JW
    Genet Med; 2022 Apr; 24(4):811-820. PubMed ID: 34949530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance.
    Giudicessi JR; Lieve KVV; Rohatgi RK; Koca F; Tester DJ; van der Werf C; Martijn Bos J; Wilde AAM; Ackerman MJ
    Circ Genom Precis Med; 2019 May; 12(5):e002510. PubMed ID: 31112425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.
    Bennett JS; Bernhardt M; McBride KL; Reshmi SC; Zmuda E; Kertesz NJ; Garg V; Fitzgerald-Butt S; Kamp AN
    Pediatr Cardiol; 2019 Dec; 40(8):1679-1687. PubMed ID: 31535183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy.
    Turkowski KL; Tester DJ; Bos JM; Haugaa KH; Ackerman MJ
    Congenit Heart Dis; 2017 Mar; 12(2):226-235. PubMed ID: 28326674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.
    Alcalde M; Campuzano O; Sarquella-Brugada G; Arbelo E; Allegue C; Partemi S; Iglesias A; Oliva A; Brugada J; Brugada R
    Clin Res Cardiol; 2015 Apr; 104(4):288-303. PubMed ID: 25398255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
    Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
    Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships.
    Olubando D; Hopton C; Eden J; Caswell R; Lowri Thomas N; Roberts SA; Morris-Rosendahl D; Venetucci L; Newman WG
    J Hum Genet; 2020 Jun; 65(6):531-539. PubMed ID: 32152366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of genetic variants associated with arrhythmogenic right ventricular cardiomyopathy in the genome aggregation database.
    Hall CL; Sutanto H; Dalageorgou C; McKenna WJ; Syrris P; Futema M
    Eur J Hum Genet; 2018 Sep; 26(9):1312-1318. PubMed ID: 29802319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized Interpretation and Clinical Translation of Genetic Variants Associated With Cardiomyopathies.
    Campuzano O; Fernandez-Falgueras A; Sarquella-Brugada G; Cesar S; Arbelo E; García-Álvarez A; Jordà P; Coll M; Fiol V; Iglesias A; Perez-Serra A; Mates J; Del Olmo B; Ferrer C; Alcalde M; Puigmulé M; Mademont-Soler I; Pico F; Lopez L; Tiron C; Brugada J; Brugada R
    Front Genet; 2019; 10():450. PubMed ID: 31156706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.
    Hall CL; Gurha P; Sabater-Molina M; Asimaki A; Futema M; Lovering RC; Suárez MP; Aguilera B; Molina P; Zorio E; Coarfa C; Robertson MJ; Cheedipudi SM; Ng KE; Delaney P; Hernández JP; Pastor F; Gimeno JR; McKenna WJ; Marian AJ; Syrris P
    Int J Cardiol; 2020 Mar; 302():124-130. PubMed ID: 31843279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.
    Blusztein DI; Zentner D; Thompson T; Jayadeva P; Liang D; Wang R; Winship I; James PA; Trainer AH; Kalman JM; Vohra J
    Heart Lung Circ; 2019 Jul; 28(7):1034-1041. PubMed ID: 30126789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic interpretation and clinical translation of minor genes related to Brugada syndrome.
    Campuzano O; Sarquella-Brugada G; Fernandez-Falgueras A; Cesar S; Coll M; Mates J; Arbelo E; Perez-Serra A; Del Olmo B; Jordá P; Fiol V; Iglesias A; Puigmulé M; Lopez L; Pico F; Brugada J; Brugada R
    Hum Mutat; 2019 Jun; 40(6):749-764. PubMed ID: 30821013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic basis of arrhythmogenic cardiomyopathy.
    Karmouch J; Protonotarios A; Syrris P
    Curr Opin Cardiol; 2018 May; 33(3):276-281. PubMed ID: 29543670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short QT Syndrome: A Comprehensive Genetic Interpretation and Clinical Translation of Rare Variants.
    Campuzano O; Fernandez-Falgueras A; Lemus X; Sarquella-Brugada G; Cesar S; Coll M; Mates J; Arbelo E; Jordà P; Perez-Serra A; Del Olmo B; Ferrer-Costa C; Iglesias A; Fiol V; Puigmulé M; Lopez L; Pico F; Brugada J; Brugada R
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31315195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective.
    Chen K; Song J; Wang Z; Rao M; Chen L; Hu S
    Clin Cardiol; 2018 May; 41(5):615-622. PubMed ID: 29750433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy.
    Singer ES; Ingles J; Semsarian C; Bagnall RD
    Circ Genom Precis Med; 2019 Jan; 12(1):e002368. PubMed ID: 30645170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. It Is Not Carved in Stone-The Need for a Genetic Reevaluation of Variants in Pediatric Cardiomyopathies.
    Westphal DS; Pollmann K; Marschall C; Wacker-Gussmann A; Oberhoffer-Fritz R; Laugwitz KL; Ewert P; Wolf CM
    J Cardiovasc Dev Dis; 2022 Jan; 9(2):. PubMed ID: 35200695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial Recurrent Myocarditis Triggered by Exercise in Patients With a Truncating Variant of the Desmoplakin Gene.
    Poller W; Haas J; Klingel K; Kühnisch J; Gast M; Kaya Z; Escher F; Kayvanpour E; Degener F; Opgen-Rhein B; Berger F; Mochmann HC; Skurk C; Heidecker B; Schultheiss HP; Monserrat L; Meder B; Landmesser U; Klaassen S
    J Am Heart Assoc; 2020 May; 9(10):e015289. PubMed ID: 32410525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.